Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy.

Saved in:
Bibliographic Details
Title: Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy.
Authors: Khan Z; Genentech, 1 DNA Way, South San Francisco, 94080, USA. khanz12@gene.com., Jung M; Genentech, 1 DNA Way, South San Francisco, 94080, USA., Crow M; Genentech, 1 DNA Way, South San Francisco, 94080, USA., Mohindra R; F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070, Basel, Switzerland., Maiya V; Genentech, 1 DNA Way, South San Francisco, 94080, USA., Kaminker JS; Genentech, 1 DNA Way, South San Francisco, 94080, USA., Hackos DH; Genentech, 1 DNA Way, South San Francisco, 94080, USA., Chandler GS; F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070, Basel, Switzerland., McCarthy MI; Genentech, 1 DNA Way, South San Francisco, 94080, USA., Bhangale T; Genentech, 1 DNA Way, South San Francisco, 94080, USA. tusharb@gene.com.
Source: Genome medicine [Genome Med] 2023 Jun 21; Vol. 15 (1), pp. 45. Date of Electronic Publication: 2023 Jun 21.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first